Influence of aromatase and epidermal growth factor receptor inhibitors in non-small cell lung cancer

被引:0
|
作者
Kritikou, I. [1 ]
Giannopoulou, E. [1 ]
Koutras, A. K. [1 ]
Kalofonos, H. P. [1 ]
机构
[1] Univ Patras, Dept Med, Patras, Greece
来源
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词
D O I
10.1016/S1359-6349(09)71872-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:553 / 553
页数:1
相关论文
共 50 条
  • [41] Activation of the Hedgehog pathway mediates resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Chen, Hualin
    Yang, Donghong
    Wang, Yongcun
    Tao, Hua
    Luo, Yiping
    Wu, Aibing
    Li, Shujun
    Yang, Zhixiong
    Chen, Ming
    JOURNAL OF CANCER, 2022, 13 (03): : 987 - 997
  • [42] Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Engelman, Jeffrey A.
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (10) : 2895 - 2899
  • [43] Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
    Gao, Yuan
    Song, PingPing
    Li, Hui
    Guo, HongBo
    Jia, Hui
    Zhang, BaiJiang
    ONCOTARGETS AND THERAPY, 2016, 9 : 13 - 20
  • [44] Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Riely, Gregory J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S146 - S149
  • [45] Epidermal growth factor receptor mutations in non-small cell lung cancer: Predicting clinical response to kinase inhibitors
    Sequist, LV
    Haber, DA
    Lynch, TJ
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 5668 - 5670
  • [46] Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
    Li, Xiaoling
    Huang, Riming
    Li, Mingyue
    Zhu, Zheng
    Chen, Zhiyan
    Cui, Liao
    Luo, Hui
    Luo, Lianxiang
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [47] Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
    Xiaoling Li
    Riming Huang
    Mingyue Li
    Zheng Zhu
    Zhiyan Chen
    Liao Cui
    Hui Luo
    Lianxiang Luo
    Cancer Cell International, 20
  • [48] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
  • [49] UNCOMMON EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Oyaert, M.
    Demedts, I.
    Boone, E.
    Van Dorpe, J.
    De Laere, E.
    Breyne, J.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S44 - S44
  • [50] Epidermal growth factor receptor mutations in Chinese patients with non-small cell lung cancer
    Zhou, C
    Su, B
    Zhao, Y
    LUNG CANCER, 2005, 49 : S153 - S153